Incident Type 2 Diabetes Risk of Selective Estrogen Receptor Modulators in Female Patients with Breast Cancer.

Pharmaceuticals (Basel) · 2021 · PMC8472249 · PMID 34577625

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

Although the rate of new-onset diabetes was 1.8 times higher among long-term toremifene users than in non-users (8.3% versus 4.7%), it did not reach statistical significance ( p = 0.06) in this PS-matched subgroup analysis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.